Related references
Note: Only part of the references are listed.Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
Young Eun Ahn et al.
GUT AND LIVER (2021)
Expanding indications for liver transplantation in the era of liver transplant oncology
Guergana Panayotova et al.
WORLD JOURNAL OF GASTROINTESTINAL SURGERY (2021)
Prognostic Accuracy of the ADV Score Following Resection of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
Shin Hwang et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2021)
Variceal bleeding is aggravated by portal venous invasion of hepatocellular carcinoma: a matched nested case-control study
Jihye Lim et al.
BMC CANCER (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma
Hideki Iwamoto et al.
CANCERS (2021)
Impact of splenomegaly and splenectomy on prognosis in hepatocellular carcinoma with portal vein tumor thrombus treated with hepatectomy
Zong-Tao Chai et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Pattern of macrovascular invasion in hepatocellular carcinoma
Maria Guarino et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)
Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update
Masatoshi Kudo et al.
LIVER CANCER (2021)
Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma
Jie Mei et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2021)
Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study
Xiaoyan Ding et al.
CANCER (2021)
Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial
Peter R. Galle et al.
LANCET ONCOLOGY (2021)
A meta-analysis of the efficacy and safety of adjuvant sorafenib for hepatocellular carcinoma after resection
Shenglan Huang et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2021)
Liver transplantation: would it be the best and last chance of cure for hepatocellular carcinoma with major venous invasion?
Ka Wing Ma et al.
HEPATOBILIARY SURGERY AND NUTRITION (2021)
Safety and efficacy of drug-eluting bead transarterial chemoembolization with CalliSpheres® microsphere for hepatocellular carcinoma with portal vein tumor thrombus: a preliminary study
Tan-Yang Zhou et al.
JOURNAL OF CANCER (2021)
Hepatic Arterial Infusion Chemotherapy Combined with Radiation Therapy for Advanced Hepatocellular Carcinoma with Tumor Thrombosis of the Main Trunk or Bilobar of the Portal Vein
Yumi Kosaka et al.
LIVER CANCER (2021)
Evaluation of the Efficacy and Toxicity of Radiotherapy for Type III-IV Portal Vein Tumor Thrombi
Shuheng Bai et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2021)
Comparison of Liver Transplantation and Liver Resection for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Type I and Type II
Jia-Yu Lv et al.
YONSEI MEDICAL JOURNAL (2021)
Report of the 20th Nationwide follow-up survey of primary liver cancer in Japan
Masatoshi Kudo et al.
HEPATOLOGY RESEARCH (2020)
Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2018 Edition)
Shuqun Cheng et al.
LIVER CANCER (2020)
Actual long-term survival in HCC patients with portal vein tumor thrombus after liver resection: a nationwide study
Zhen-Hua Chen et al.
HEPATOLOGY INTERNATIONAL (2020)
Embolotherapeutic Strategies for Hepatocellular Carcinoma: 2020 Update
Sirish A. Kishore et al.
CANCERS (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
Kazuomi Ueshima et al.
LIVER CANCER (2020)
Sorafenib combined with embolization plus hepatic arterial infusion chemotherapy for inoperable hepatocellular carcinoma
Bao-Jiang Liu et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2020)
Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion
Sojung Han et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2020)
Survival benefits from adjuvant transcatheter arterial chemoembolization in patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysis
Lei Liang et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2020)
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
Jian Zhou et al.
LIVER CANCER (2020)
Role of External Beam Radiotherapy in Hepatocellular Carcinoma
Chien Peter Chen
CLINICS IN LIVER DISEASE (2020)
Epigenome-wide DNA methylation profiling of portal vein tumor thrombosis (PVTT) tissues in hepatocellular carcinoma patients
Xiaoxiao Fan et al.
NEOPLASIA (2020)
A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea
Jae Seung Lee et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2020)
Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma
Kai-Cai Liu et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
Evolving thresholds for liver transplantation in hepatocellular carcinoma: A Western experience
Michelle R. Ju et al.
ANNALS OF GASTROENTEROLOGICAL SURGERY (2020)
Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma
Valerie Chew et al.
GUT (2019)
Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis
Nicolas M. Intagliata et al.
GASTROENTEROLOGY (2019)
90Y-Loaded Microsphere SIRT of HCC Patients With Portal Vein Thrombosis: High Clinical Impact of 99mTc-MAA SPECT/CT-Based Dosimetry
Etienne Garin et al.
SEMINARS IN NUCLEAR MEDICINE (2019)
2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
Joong-Won Park et al.
GUT AND LIVER (2019)
Hepatobiliary Cancers, Version 2.2019 Featured Updates to the NCCN Guidelines
Al B. Benson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion A Randomized Clinical Trial
MinKe He et al.
JAMA ONCOLOGY (2019)
Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study
Wenzhe Fan et al.
CLINICAL THERAPEUTICS (2019)
Tumor Microenvironment as A Game Changer in Cancer Radiotherapy
Magdalena Jarosz-Biej et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Neoadjuvant Three-Dimensional Conformal Radiotherapy for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Randomized, Open-Label, Multicenter Controlled Study
Xubiao Wei et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis
Thomas Yau et al.
JOURNAL OF HEPATOLOGY (2019)
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma
Jens Ricke et al.
JOURNAL OF HEPATOLOGY (2019)
Integrative molecular analysis of metastatic hepatocellular carcinoma
Dongfang Wang et al.
BMC MEDICAL GENOMICS (2019)
Safety and Efficacy of Transcatheter Arterial Chemoembolization Plus Radiotherapy Combined With Sorafenib in Hepatocellular Carcinoma Showing Macrovascular Invasion
Yuting Zhao et al.
FRONTIERS IN ONCOLOGY (2019)
An Eastern Hepatobiliary Surgery Hospital/Portal Vein Tumor Thrombus Scoring System as an Aid to Decision Making on Hepatectomy for Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombus: A Multicenter Study
Xiu-Ping Zhang et al.
HEPATOLOGY (2019)
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2019)
Extent of portal vein tumour thrombosis in patients with hepatocellular carcinoma: The more, the worse?
Aline Maehringer-Kunz et al.
LIVER INTERNATIONAL (2019)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Comparison of radiation therapy modalities for hepatocellular carcinoma with portal vein thrombosis: A meta-analysis and systematic review
Chai Hong Rim et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Prospective longitudinal quality of life and survival outcomes in patients with advanced infiltrative hepatocellular carcinoma and portal vein thrombosis treated with Yttrium-90 radioembolization
Minzhi Xing et al.
BMC CANCER (2018)
Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis
Jong Hwan Choi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
The role of liver resection in the management of intermediate and advanced stage hepatocellular carcinoma. A systematic review
G. K. Glantzounis et al.
EJSO (2018)
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice
Edoardo Giovanni Giannini et al.
HEPATOLOGY (2018)
Hepatic resection compared to chemoembolization in intermediate- to advanced-stage hepatocellular carcinoma: A meta-analysis of high-quality studies
Myung Han Hyun et al.
HEPATOLOGY (2018)
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
Pierce K. H. Chow et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion
Carlo Spreafico et al.
JOURNAL OF HEPATOLOGY (2018)
Portal vein tumor thrombosis has a direct impact on liver function
R. Kloeckner et al.
JOURNAL OF HEPATOLOGY (2018)
Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma
Ning Lyu et al.
JOURNAL OF HEPATOLOGY (2018)
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
Chung-Kwe Wang
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2018)
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
G. K. Abou-Alfa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis
Kenichiro Kodama et al.
ONCOLOGY (2018)
Prognostic Prediction Models for Resection of Large Hepatocellular Carcinoma: A Korean Multicenter Study
Shin Hwang et al.
WORLD JOURNAL OF SURGERY (2018)
Efficacy and Safety of Transarterial Chemoembolization Plus External Beam Radiotherapy vs Sorafenib in Hepatocellular Carcinoma With Macroscopic Vascular Invasion A Randomized Clinical Trial
Sang Min Yoon et al.
JAMA ONCOLOGY (2018)
Growth velocity of the portal vein tumor thrombus accelerated by its progression, alpha-fetoprotein level, and liver fibrosis stage in patients with hepatocellular carcinoma
Hidetoshi Gon et al.
SURGERY (2018)
A systematic review comparing outcomes of surgical resection and non-surgical treatments for patients with hepatocellular carcinoma and portal vein tumor thrombus
Lei Liang et al.
HPB (2018)
Association of Preoperative Antiviral Treatment With Incidences of Microvascular Invasion and Early Tumor Recurrence in Hepatitis B Virus-Related Hepatocellular Carcinoma
Zheng Li et al.
JAMA SURGERY (2018)
Better surgical treatment method for hepatocellular carcinoma with portal vein tumor thrombus
Shu-You Peng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Transarterial chemoembolization for hepatocellular carcinoma combined with portal vein tumor thrombosis
Wei-Fu Lv et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Liver Transplantation After Transarterial Chemoembolization and Radiotherapy for Hepatocellular Carcinoma with Vascular Invasion
Yuri Jeong et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2017)
Macrovascular Invasion Is Not an Absolute Contraindication for Living Donor Liver Transplantation
Kwang-Woong Lee et al.
LIVER TRANSPLANTATION (2017)
Personalized treatment of patients with very early hepatocellular carcinoma
Alessandro Vitale et al.
JOURNAL OF HEPATOLOGY (2017)
Antiviral Therapy Inhibits Viral Reactivation and Improves Survival after Repeat Hepatectomy for Hepatitis B Virus-Related Recurrent Hepatocellular Carcinoma
Shengyu Huang et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2017)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry et al.
LANCET (2017)
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
Valerie Vilgrain et al.
LANCET ONCOLOGY (2017)
The Clinical Outcomes of Patients with Portal Vein Tumor Thrombi After Living Donor Liver Transplantation
Ho Joong Choi et al.
LIVER TRANSPLANTATION (2017)
The possibility of radiotherapy as downstaging to living donor liver transplantation for hepatocellular carcinoma with portal vein tumor thrombus
Jin Y. Choi et al.
LIVER TRANSPLANTATION (2017)
Recent Developments in Radiotherapy
Deborah E. Citrin
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus
Zi-Han Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Indication for surgical resection in patients with hepatocellular carcinoma with major vascular invasion
Tokio Higaki et al.
BIOSCIENCE TRENDS (2017)
Hepatectomy after down-staging of hepatocellular carcinoma with portal vein tumor thrombus using chemoradiotherapy: A retrospective cohort study
Michinori Hamaoka et al.
INTERNATIONAL JOURNAL OF SURGERY (2017)
Sorafenib versus Hepatic Arterial Infusion Chemotherapy as Initial Treatment for Hepatocellular Carcinoma with Advanced Portal Vein Tumor Thrombosis
Michihisa Moriguchi et al.
LIVER CANCER (2017)
Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis
Xiu-Ping Zhang et al.
BMC CANCER (2017)
Hepatitis B virus infection and active replication promote the formation of vascular invasion in hepatocellular carcinoma
Xubiao Wei et al.
BMC CANCER (2017)
Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis
Julien Edeline et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Efficacy and safety of preoperative chemoembolization for resectable hepatocellular carcinoma with portal vein invasion: a prospective comparative study
Yong-Fa Zhang et al.
EUROPEAN RADIOLOGY (2016)
Endovascular brachytherapy combined with stent placement and TACE for treatment of HCC with main portal vein tumor thrombus
Jian-Jun Luo et al.
HEPATOLOGY INTERNATIONAL (2016)
Characterization of Portal Vein Thrombosis (Neoplastic Versus Bland) on CT Images Using Software-Based Texture Analysis and Thrombus Density (Hounsfield Units)
Rodrigo Canellas et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2016)
Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial
M. Ikeda et al.
ANNALS OF ONCOLOGY (2016)
Role of the Microenvironment in Liver Metastasis: From Pre- to Prometastatic Niches
Pnina Brodt
CLINICAL CANCER RESEARCH (2016)
Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysis
Antonio Facciorusso et al.
DIGESTIVE AND LIVER DISEASE (2016)
Survival benefit of chemoembolization plus Iodine125 seed implantation in unresectable hepatitis B-related hepatocellular carcinoma with PVTT: a retrospective matched cohort study
Mingsheng Huang et al.
EUROPEAN RADIOLOGY (2016)
Lipiodol Transarterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review of Efficacy and Safety Data
Riccardo Lencioni et al.
HEPATOLOGY (2016)
Report of the 19th follow-up survey of primary liver cancer in Japan
Masatoshi Kudo et al.
HEPATOLOGY RESEARCH (2016)
Multiplication of Tumor Volume by Two Tumor Markers Is a Post-Resection Prognostic Predictor for Solitary Hepatocellular Carcinoma
Shin Hwang et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2016)
Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion
Takashi Kokudo et al.
JOURNAL OF HEPATOLOGY (2016)
Hepatocellular carcinoma with main portal vein tumor thrombus: a comparative study comparing hepatectomy with or without neoadjuvant radiotherapy
Nan Li et al.
HPB (2016)
Liver resection with thrombectomy as a treatment of hepatocellular carcinoma with major vascular invasion: results from a retrospective multicentric study
Benedetta Pesi et al.
AMERICAN JOURNAL OF SURGERY (2015)
Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
Roman Kloeckner et al.
BMC CANCER (2015)
Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
Jessica Zucman-Rossi et al.
GASTROENTEROLOGY (2015)
Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma
Tomokazu Kawaoka et al.
JOURNAL OF DIGESTIVE DISEASES (2015)
Transarterial chemoembolization: Modalities, indication, and patient selection
Wolfgang Sieghart et al.
JOURNAL OF HEPATOLOGY (2015)
Comparison of Chemoembolization with and without Radiation Therapy and Sorafenib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Propensity Score Analysis
Gi-Ae Kim et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2015)
Vascular invasion in hepatitis B virus-related hepatocellular carcinoma with underlying cirrhosis: possible associations with ascites and hepatitis B viral factors?
Chuan Chen et al.
TUMOR BIOLOGY (2015)
Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus: a novel classification
Jiang-feng Xu et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2015)
Comparative transcriptome analysis reveals that the extracellular matrix receptor interaction contributes to the venous metastases of hepatocellular carcinoma
Hong Zhang et al.
CANCER GENETICS (2015)
Transcatheter Arterial Chemoembolization Plus Radiotherapy Compared With Chemoembolization Alone for Hepatocellular Carcinoma A Systematic Review and Meta-analysis
Ya Ruth Huo et al.
JAMA ONCOLOGY (2015)
Role of 3-D conformal radiotherapy for major portal vein tumor thrombosis combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma
Hatsue Fujino et al.
HEPATOLOGY RESEARCH (2015)
A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
Do Seon Song et al.
JOURNAL OF GASTROENTEROLOGY (2015)
Survival analysis of proposed BCLC-B subgroups in hepatocellular carcinoma patients
Arndt Weinmann et al.
LIVER INTERNATIONAL (2015)
The role of 18F-FDG PET/CT in differentiating malignant from benign portal vein thrombosis
Shengping Hu et al.
ABDOMINAL IMAGING (2014)
Surgical Resection Versus Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Propensity Score Analysis
Po-Hong Liu et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis
Takahide Nakazawa et al.
BMC GASTROENTEROLOGY (2014)
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
R. Golfieri et al.
BRITISH JOURNAL OF CANCER (2014)
Safety and efficacy of transarterial chemoembolization plus sorafenib for hepatocellular carcinoma with portal venous tumour thrombus
T. Pan et al.
CLINICAL RADIOLOGY (2014)
Multimodal treatment of hepatocellular carcinoma
Dirk Graf et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2014)
Development of Hong Kong Liver Cancer Staging System With Treatment Stratification for Patients With Hepatocellular Carcinoma
Thomas Yau et al.
GASTROENTEROLOGY (2014)
Clinical outcomes of a cohort series of patients with hepatocellular carcinoma in a hepatitis B virus-endemic area
Hee-Won Kwak et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Treatment with Transarterial Chemoembolization Combined with Sorafenib-A Retrospective Controlled Study
Kangshun Zhu et al.
RADIOLOGY (2014)
Newer treatments for advanced hepatocellular carcinoma
Myeong Jun Song et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2014)
Role of External Beam Radiation Therapy in Management of Hepatocellular Carcinoma
Hanish Sharma
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2014)
Resection of Hepatocellular Carcinoma with Macroscopic Vascular Invasion
Sasan Roayaie et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Practical Effect of Sorafenib Monotherapy on Advanced Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis
Soung Won Jeong et al.
GUT AND LIVER (2013)
Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus
Zhen-Wei Peng et al.
CANCER (2012)
Comparison of survival and quality of life of hepatectomy and thrombectomy using total hepatic vascular exclusion and chemotherapy alone in patients with hepatocellular carcinoma and tumor thrombi in the inferior vena cava and hepatic vein
Jianping Liu et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)
MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma
Shupeng Liu et al.
JOURNAL OF HEPATOLOGY (2012)
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
Jordi Bruix et al.
JOURNAL OF HEPATOLOGY (2012)
Factors linked to longterm survival of patients with hepatocellular carcinoma accompanied by tumour thrombus in the major portal vein after surgical resection
Rumi Matono et al.
HPB (2012)
A new classification for hepatocellular carcinoma with portal vein tumor thrombus
Jie Shi et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2011)
Surgical Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
Jie Shi et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
Johannes Lammer et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2010)
Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects
Alejandro Forner et al.
SEMINARS IN LIVER DISEASE (2010)
Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombus Treatment With 3-Dimensional fConformal Radiotherapy After Portal Vein Stenting and Transarterial Chemoembolization
Xue-Bin Zhang et al.
CANCER (2009)
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
Vincenzo Mazzaferro et al.
LANCET ONCOLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Current Management of Hepatocellular Carcinoma
Manuel Mendizabal et al.
MEDICAL CLINICS OF NORTH AMERICA (2009)
A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria
M. L. Volk et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Comparison of three current staging systems for hepatocellular carcinoma: Japan integrated staging score, new Barcelona Clinic Liver Cancer staging classification, and Tokyo score
Hobyung Chung et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Validation of a New Prognostic Staging System for Hepatocellular Carcinoma: A Comparison of the Biomarker-Combined Japan Integrated Staging Score, the Conventional Japan Integrated Staging Score and the BALAD Score
Satoshi Kitai et al.
ONCOLOGY (2008)
Outcomes of Neoadjuvant Transarterial Chemoembolization to Downstage Hepatocellular Carcinoma Before Liver Transplantation
William C. Chapman et al.
ANNALS OF SURGERY (2008)
Models, mechanisms and clinical evidence for cancer dormancy
Julio A. Aguirre-Ghiso
NATURE REVIEWS CANCER (2007)
Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan
Iwao Ikai et al.
HEPATOLOGY RESEARCH (2007)
Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy
L. Tarantino et al.
ABDOMINAL IMAGING (2006)
Clinical features, biochemical parameters, and virological profiles of patients with hepatocellular carcinoma in Hong Kong
T. -K. Cheung et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma
XP Chen et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the major portal vein
I Ikai et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2006)
Clinical presentation and natural course of hepatocellular carcinoma
ES Bialecki et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2005)
Report of the 15th follow-up survey of primary liver cancer
I Ikai et al.
HEPATOLOGY RESEARCH (2004)
Hepatocellular carcinoma: Diagnosis and treatment
AS Befeler et al.
GASTROENTEROLOGY (2002)
Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the cancer of the Liver Italian Program staging system - A study based on 926 patients
TWT Leung et al.
CANCER (2002)
Portal vein thrombosis in adults: pathophysiology, pathogenesis and management
DC Valla et al.
JOURNAL OF HEPATOLOGY (2000)
Share Paper
